EXOSOME THERAPEUTICS

A Revolution In Healthcare

Innovating PnD Exosome Therapeutics

  • Smart Manufacturing

    We leverage cutting-edge advancements in bio-manufacturing technologies and processes to facilitate the development and production of regenerative therapies, focusing on Perinatal-Derived (PnD) exosome therapeutics.

  • Advanced Analytics

    The integration of cutting-edge analytical methodologies and AI technologies is a cornerstone of our approach to ensuring high standards of efficacy and safety in our products.

  • Transformative Therapies

    We leverage the regenerative potential of perinatal-derived tissues, such as amniotic fluid, cord blood, umbilical cord, and placenta, to develop advanced cell-free exosome therapeutics that retain the healing properties of their parent cells while minimizing the risk of post-transplant adverse events associated with cell therapies.

At KweHealth, we stand at the forefront of regenerative science as a pioneering Integrated Development and Manufacturing Organization (IDMO). Our mission is to harness the regenerative potential of Perinatal-Derived (PnD) exosome to confront and treat intractable diseases. Our primary focus is to bridge essential deficiencies in regenerative medicine, particularly in the realm of addressing tissue and organ injuries by means of non-invasive exosome treatments. By integrating applied research with cutting-edge biomanufacturing technologies and advanced analytics, we strive to unlock new potentials in healthcare.

News & Events

  • Marquis Who's Who

    Mercedes F. Kweh, PhD, Recognized for Expertise in Biotechnology

    Click Here

  • WomLEAD Magazine

    KweHealth and our CEO were featured in a WomLEAD article!

    Click Here

  • Meet HydroKarma!

    Stay tuned for the launch of our new skincare line, HydroKarma.

    Click Here
Upcoming Events
Close-Up Television & Radio Interview, Part 1
Jun 20
Close-Up Television & Radio Interview, Part 1

The first of a highly anticipated two-part interview series with host Doug Llewelyn about Regenerative Medicine.

Close-Up Television & Radio Interview, Part 2
Jun 27
Close-Up Television & Radio Interview, Part 2

The second part of an enthralling two-part interview series, this time exclusively with Jim Masters.

Expert Speaker at 6th Annual Exosome-Based Therapeutic Development Summit
Sep 17
Expert Speaker at 6th Annual Exosome-Based Therapeutic Development Summit

KweHealth's CEO, Mercedes Kweh, PhD, has been invited as an expert speaker.

Interview with Dr. Emil Mondoa
Sep 30
Interview with Dr. Emil Mondoa

Interview with Dr. Emil Mondoa, author of “Sugars That Heal: The New Healing Science of Glyconutrients.

Past Events
BioFlorida Celebration of Biotechnology | Alachua
Apr 25
BioFlorida Celebration of Biotechnology | Alachua

KweHealth was in attendance of BioFlorida’s celebration of biotechnology this April at Momentum Labs in Alachua, Florida.

17th Annual Business of Biotech
Feb 23
17th Annual Business of Biotech

KweHealth was in attendance at the 17th Annual Business of Biotech conference at the Moffit Cancer Center, Tampa FL.

Advanced Therapies Week 2024
Jan 16
Advanced Therapies Week 2024

In January 2024, KweHealth was privileged to attend it’s first ATW event at the Miami Beach Convention Center.

Co-Founder and CEO

Mercedes F. Kweh, MSL-cert., MSc., PhD.

Mercedes is an accomplished and versatile leader with over 20 years of experience as a Medical Research Immunologist. She has contributed to numerous peer-reviewed publications in the fields of immunology, infectious diseases and regenerative medicine. She brings a wealth of experience and expertise in the development of medical and commercial strategies, pre-clinical and clinical study design, and a comprehensive understanding of regulatory pathways pertaining to drug development.